주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
Updated : Thursday, Aprill 18, 2024, 17:11
Home
Login
Sign in
한국어
National
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
Macro-Economics
Trade
Foreign Exchanges
Industries
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
Company & Stock Tracking
Market Trend & Outlook
Finance
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
Science
New Tech
Blockchain
ESG
Environment
Social
Governance
Event
Exhibitions
Conferences
People
K-Culture
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
Editorials
Contributions
Who's Who
기사검색
검색
All articles
List
Subject Type
Summary Type
Photo Type
Did the FSS Change Its Logic about Samsung BioLogics’ Accounting Fraud Allegations?
이미지기사
Finance
Michael Herh
2018.06.18 14:25
SFC to Rule on Samsung BioLogics Issue on June 7
이미지기사
Industries
Choi Mun-hee
2018.06.01 13:45
Decision on Samsung BiolLogics Hinges on Interpretation of IFRS
이미지기사
Industries
Jung Suk-yee
2018.05.24 10:33
Financial Authority to Speed up Review of Fraud Allegations against Samsung BioLogics
이미지기사
Industries
Jung Suk-yee
2018.05.21 10:40
Samsung BioLogics to Hold FSS Responsible for Revealing Preliminary Conclusion
이미지기사
Finance
Yoon Young-sil
2018.05.18 12:21
Stock Price and Market Cap of Samsung Biologics Plummet
이미지기사
Economics
Youn Won-chang
2018.05.03 10:55
FSC Determines Samsung BioLogics Committed Accounting Fraud
이미지기사
ESG
Choi Mun-hee
2018.05.02 13:01
Will Samsung C&T Invest in Samsung Bioepis?
이미지기사
Industries
Choi Mun-hee
2018.04.27 14:07
Samsung BioLogics Jumps to Third in Market Cap in Seoul Bourse
이미지기사
Industries
Choi Mun-hee
2018.04.11 07:30
Samsung Begins Talks with Biogen to secure control of biosimilar joint venture
이미지기사
Choi Mun-hee
2018.04.11 07:00
S. Korean Products Account for 66% of the Global Market
이미지기사
Industries
Choi Mun-hee
2018.04.06 01:45
Will Samsung BioLogics Escape from Accounting Fraud Allegations?
이미지기사
ESG
Yoon Yung Sil
2018.04.02 01:30
Celltrion, Samsung Bioepis Show Poor Performance in Domestic Biosimilar Market
이미지기사
Industries
Michael Herh
2018.03.26 23:45
US FDA Initiated Procedure Regarding Samsung Bioepis’ SB3 in US
이미지기사
Industries
Choi Mun-hee
2017.12.21 02:00
Samsung Bioepis Receives Approval of Anti-Cancer Drug 'Ontruzant’ from Europe
이미지기사
Industries
Choi Mun-hee
2017.11.21 03:15
Korea’s Large Businesses Line up for Bio Pharmaceutical Business Battle
이미지기사
Industries
Choi Mun-hee
2017.11.14 01:30
Korea’s Pharmaceutical Exports Reach 3.6 Trillion Won
이미지기사
Industries
Yoon Yung Sil
2017.10.30 02:45
Korean Biosimilars Suffering from Global Pharmaceuticals’ Patents
이미지기사
Industries
Choi Mun-hee
2017.09.21 02:15
Samsung Bioepis Teams up with Japan’s Takeda to Develop Novel Biotech Drugs
이미지기사
Industries
Choi Mun-hee
2017.08.22 08:00
Korean Biosimilar Clinical Trials Approved More Than Multinational Pharma Firms’
이미지기사
Industries
Choi Mun-hee
2017.04.13 01:45
처음
이전
이전
1
2
3
4
5
끝
위로
모바일버전
All articles
National
전체
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
전체
Macro-Economics
Trade
Foreign Exchanges
Industries
전체
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
전체
Company & Stock Tracking
Market Trend & Outlook
Finance
전체
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
전체
Science
New Tech
Blockchain
ESG
전체
Environment
Social
Governance
Event
전체
Exhibitions
Conferences
People
K-Culture
전체
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
전체
Editorials
Contributions
Who's Who
전체메뉴닫기